Yang, W., Sun, Q., Xu, F., Peng, J., Xue, C., Chen, M., . . . Shi, Y. Bevacizumab, tislelizumab and nab-paclitaxel for previously untreated metastatic triple-negative breast cancer: A phase II trial. BMJ Publishing Group.
Chicago Style (17th ed.) CitationYang, Wei, et al. Bevacizumab, Tislelizumab and Nab-paclitaxel for Previously Untreated Metastatic Triple-negative Breast Cancer: A Phase II Trial. BMJ Publishing Group.
MLA (9th ed.) CitationYang, Wei, et al. Bevacizumab, Tislelizumab and Nab-paclitaxel for Previously Untreated Metastatic Triple-negative Breast Cancer: A Phase II Trial. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.